Search

Your search keyword '"Mauro FA"' showing total 152 results

Search Constraints

Start Over You searched for: Author "Mauro FA" Remove constraint Author: "Mauro FA"
152 results on '"Mauro FA"'

Search Results

1. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.

2. Study of Ground State Interactions of Enantiopure Chiral Quaternary Ammonium Salts and Amides, Nitroalkanes, Nitroalkenes, Esters, Heterocycles, Ketones and Fluoroamides

3. Mapping of regions with low tuberculosis notification and estimation of diagnostic gaps in Cameroon, evidence from OpenStreetMap and WorldPop data

4. Unveiling genetic insights: Array-CGH and WES discoveries in a cohort of 122 children with essential autism spectrum disorder

5. La libertad como precondición del desarrollo económico

6. Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference?

7. La evolución de los mecanismos de control del mercado textil murciano (1370-1500)

8. Gobernar el trabajo: la elite de la corporación pelaire y la industria textil de Murcia (1370-1500)

9. Volumetric and Linear Adaptation of an Indirect Adhesive Restoration: Comparison of Chairside 3D Printing and Milling Techniques

10. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis

11. Uniss-FGD: A Novel Dataset of Human Gazes Over Images of Faces

12. A Generative Adversarial Network (GAN) Fingerprint Approach Over LTE

13. Tau is not necessary for amyloid-β-induced synaptic and memory impairments

14. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade

15. Efficient magnetic switching in a correlated spin glass

16. Metaverse & Human Digital Twin: Digital Identity, Biometrics, and Privacy in the Future Virtual Worlds

18. Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

19. Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review

20. Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade

21. Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

23. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent

24. De la circulación a la producción: el capital genovés y la industria del tinte en Murcia (1380-1470)

25. Five decades of breeding populations census for 12 species of colonial waterbirds in northwestern Italy

26. Psoriatic Arthritis in Males and Females: Differences and Similarities

27. Privacy and Security Best Practices for IoT Solutions

28. Proceso productivo y Verlagssystem: la industria textil de Murcia durante la Baja Edad Media

29. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer’s disease

30. Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory

31. Predictability of lower incisor tip using clear aligner therapy

32. Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits

33. Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease

34. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease

35. Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

36. ?-Synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII

37. Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease

38. Correction: Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer’s disease

39. Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

40. Synaptic Fatigue is More Pronounced in the APP/PS1 Transgenic Mouse Model of Alzheimers Disease

41. Data-driven identification of communities with high levels of tuberculosis infection in the Democratic Republic of Congo

42. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

43. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits

44. Dynamin 1 Is Required for Memory Formation

45. Nonorthogonal Multiple Access and Subgrouping for Improved Resource Allocation in Multicast 5G NR

46. Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors

47. Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy

48. P3‐219: Picomolar Beta‐Amyloid progressively impairs synaptic plasticity over time while simultaneously increases spontaneous neurotransmission

49. Evolution of sensory analysis attributes and volatile aging markers in bottle fermented craft beers during storage at different temperatures.

50. Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices

Catalog

Books, media, physical & digital resources